NasdaqGS - Delayed Quote USD

Ventyx Biosciences, Inc. (VTYX)

1.2400
+0.0700
+(5.98%)
At close: May 9 at 4:00:00 PM EDT
1.2799
+0.04
+(3.22%)
After hours: May 9 at 6:33:27 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for VTYX

Recent News: VTYX

View More
Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress

Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress
GlobeNewswire 2 days ago
Great week for Ventyx Biosciences, Inc. (NASDAQ:VTYX) institutional investors after losing 70% over the previous year

Great week for Ventyx Biosciences, Inc. (NASDAQ:VTYX) institutional investors after losing 70% over the previous year
Simply Wall St. 6 days ago
Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists

Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists
GlobeNewswire last month
Ventyx Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Corporate Progress

Ventyx Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Corporate Progress
GlobeNewswire 2 months ago
Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn’s Disease at ECCO 2025

Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn’s Disease at ECCO 2025
GlobeNewswire 2 months ago
Ventyx Biosciences to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Ventyx Biosciences to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
GlobeNewswire 3 months ago
Ventyx Biosciences highlights its 2025 pipeline strategy

Ventyx Biosciences highlights its 2025 pipeline strategy
TipRanks 3 months ago
Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio

Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio
GlobeNewswire 3 months ago
We're Keeping An Eye On Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

We're Keeping An Eye On Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate
Simply Wall St. 3 months ago
Ventyx Biosciences Insiders Land Bargain With Gains Of US$180k

Ventyx Biosciences Insiders Land Bargain With Gains Of US$180k
Simply Wall St. 4 months ago
Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) latest 15% decline adds to one-year losses, institutional investors may consider drastic measures

Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) latest 15% decline adds to one-year losses, institutional investors may consider drastic measures
Simply Wall St. 5 months ago
View More

Related Tickers

HLVX HilleVax, Inc.
1.9000
-0.52%
 
ASMB Assembly Biosciences, Inc.
12.24
+4.97%
 
EPIX ESSA Pharma Inc.
1.7200
+0.58%
 
ANTX AN2 Therapeutics, Inc.
1.2000
-1.64%
 
KZR Kezar Life Sciences, Inc.
4.2200
+2.43%
 
SPRO Spero Therapeutics, Inc.
0.6200
+7.83%
 
RPTX Repare Therapeutics Inc.
1.3600
0.00%
 
TBPH Theravance Biopharma, Inc.
8.98
-9.29%
 
CLRB Cellectar Biosciences, Inc.
0.2474
-1.63%
 
KROS Keros Therapeutics, Inc.
13.65
-2.64%